Taselisib, a PI3K inhibitor, alleviates neuropathic pain through HIF-1a-mediated angiogenesis in a rat model of chronic constriction injury.

You HP, Zhang LH, Li CY, He HF, Chen ZY, Wang HG, Liu WF, Xu CJ

DOI: 10.1159/nim/adxag005
Published: 2026 Sep 9
Container: Neuroimmunomodulation
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/nim/adxag005,
  title = {Taselisib, a PI3K inhibitor, alleviates neuropathic pain through HIF-1a-mediated angiogenesis in a rat model of chronic constriction injury.},
  author = {You HP and Zhang LH and Li CY and He HF and Chen ZY and Wang HG and Liu WF and Xu CJ},
  year = {2026},
  journal = {Neuroimmunomodulation},
  doi = {10.1159/nim/adxag005},
  url = {https://doi.org/10.1159/nim/adxag005}
}

RIS

TY  - JOUR
TI  - Taselisib, a PI3K inhibitor, alleviates neuropathic pain through HIF-1a-mediated angiogenesis in a rat model of chronic constriction injury.
AU  - You HP
AU  - Zhang LH
AU  - Li CY
AU  - He HF
AU  - Chen ZY
AU  - Wang HG
AU  - Liu WF
AU  - Xu CJ
PY  - 2026
JO  - Neuroimmunomodulation
DO  - 10.1159/nim/adxag005
UR  - https://doi.org/10.1159/nim/adxag005
ER  -

APA

HP, Y., LH, Z., CY, L., HF, H., ZY, C., HG, W., WF, L., & CJ, X. (2026). Taselisib, a PI3K inhibitor, alleviates neuropathic pain through HIF-1a-mediated angiogenesis in a rat model of chronic constriction injury.. Neuroimmunomodulation. https://doi.org/10.1159/nim/adxag005

Source records

pubmed · retrieved 2026-09-25T14:53:23.390Z